Lixte Biotechnology Inc. (LIXT)
1.33
0.03 (2.31%)
At close: Mar 03, 2025, 3:58 PM
1.21
-9.02%
After-hours: Mar 03, 2025, 03:59 PM EST
Lixte Biotechnology Ratios Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 |
PE Ratio | -0.88 | -0.13 | -2.38 | -10.95 | -19.07 | -25.63 | -5.25 | -3.14 | -4.92 | -3.85 | -3.93 | -2.72 | -8.5K | -13.81K | -92.6K | -125.18K | -121.51K | -2.1M | -3.7M |
PEG Ratio | 0.01 | -0.00 | -0.03 | -0.31 | 10.39 | -2.07 | 0.19 | 0.12 | 2.30 | -0.04 | 0.06 | -0.00 | -63.78 | 259.98 | -5K | 4.63K | -658.18 | -24.47K | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 70.11 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.12 | 0.16 | 3.35 | 7.13 | 18.73 | 13.25 | 9.53 | 31.17 | 44.89 | 40.08 | 22.88 | 6.53 | 222.53K | 7K | 110.42K | -491.95K | 531.42K | 1.63M | -15.44M |
P/FCF Ratio | -1.05 | -0.17 | -3.87 | -16.77 | -27.23 | -36.19 | -6.72 | -3.99 | -6.43 | -6.52 | -4.58 | -8.07 | -12.93K | -12.98K | -225.02K | -266.31K | -284.87K | -2.31M | -3.7M |
P/OCF Ratio | -1.05 | -0.17 | -3.87 | -16.77 | -27.23 | -36.19 | -6.72 | -3.99 | -6.43 | -6.52 | -4.58 | -8.07 | -12.93K | -12.98K | -225.02K | -266.31K | -284.98K | -2.31M | -3.7M |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -10.91 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.31 | n/a | n/a | n/a |
Quick Ratio | 13.73 | 14.08 | 16.81 | 24.15 | 11.23 | 20.55 | 3.67 | 1.98 | 1.88 | 1.97 | 1.73 | 6.71 | 1.23 | 9.67 | 5.33 | 0.14 | 2.49 | 6.02 | 0.37 |
Current Ratio | 13.73 | 14.08 | 16.81 | 24.15 | 11.23 | 20.55 | 3.67 | 1.98 | 2.09 | 1.97 | 1.73 | 6.71 | 1.23 | 9.90 | 5.33 | 0.14 | 2.49 | 6.02 | 0.37 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.33 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | -711.15 | -906.45 | -889.07 | n/a | -434.3 | -1.32K | -11.67K | -33.93K | -36.41K | -458.28K | -263.22K | -14.95K | -614.84 | -1.26K | -1.03K | n/a | n/a | n/a |
Return on Equity (ROE) | -1.27 | -1.22 | -1.41 | -0.65 | -0.98 | -0.52 | -1.82 | -9.94 | -9.13 | -10.4 | -5.82 | -2.4 | -26.17 | -0.51 | -1.19 | 3.93 | -4.37 | -0.78 | 4.18 |
Return on Assets (ROA) | -1.18 | -1.13 | -1.32 | -0.62 | -0.89 | -0.49 | -1.32 | -4.93 | -4.77 | -5.13 | -2.46 | -2.04 | -4.81 | -0.46 | -0.97 | -24.62 | -2.62 | -0.65 | -7.1 |
Return on Capital (ROIC) | -1.27 | -1.22 | -1.4 | -0.65 | -1.02 | -0.52 | -1.82 | -9.94 | -8.47 | -9.04 | -5.82 | -1.41 | -23.64 | -0.51 | -1.19 | 3.94 | -4.4 | -0.8 | 4.18 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.00 | -0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.43K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.43K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.32K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.09K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.22K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |